U ncoupling proteins (UCPs), which are located in the mitochondrial inner membrane, partially dissipate the proton electrochemical gradient. 1 The best characterized uncoupling protein, UCP1, is exclusively expressed in brown adipose tissue and is a key molecule in thermogenesis. 1 UCP2, another member of the UCP family, 2, 3 is expressed in various tissues, including the brain, lung, spleen, kidney, liver, adipose tissues, and heart. [1] [2] [3] Recently, UCP2 was reported to regulate insulin secretion from pancreatic islets by regulating ATP concentration. 4 -6 Furthermore, UCP2 reportedly contributed to immune response to infection by regulating reactive oxygen species (ROS) production. 7 These findings suggest that the physiological role of UCP2 may be organ specific; however, its function in the heart remains unknown.
Mitochondrial ATP-sensitive potassium (mitoK ATP ) channels have cardioprotective effects against ischemia/reperfusion injury. 8, 9 The mitoK ATP channel opener diazoxide prevents apoptosis induced by oxidative stress in cultured cardiomyocytes. 10 Partial depolarization of mitochondrial inner membrane potential (⌬⌿ m ) achieved by the opening of mitoK ATP channels and subsequent inhibition of mitochondrial Ca 2ϩ overload have been proposed as potential mechanisms of this effect. 11, 12 Similarly, low concentrations of mitochondrial uncouplers such as carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) or 2,4-dinitrophenol were reported to have cytoprotective effects. FCCP prevented permeability transition pore (PTP) opening and ROS production induced by staurosporine or chelerythrine in isolated mitochondria from rat liver 13, 14 ; 2,4-dinitrophenol reduced infarct size and preserved cardiac function in a rat model of myocardial ischemia/reperfusion injury. 15 These results suggest that depolarization of ⌬⌿ m is responsible for cytoprotection. Furthermore, UCP2 overexpression in murine macrophages reduced ROS generation induced by lipopolysaccharide. 16 Based on these observations, we hypothesized that UCP2 may have protective effects against oxidative stress in the heart. Using an adenoviral vector, we investigated the effects of UCP2 overexpression on cell injury induced by hydrogen peroxide (H 2 O 2 ) in cultured cardiomyocytes.
In Vitro Transduction
Adenovirus (AdEGI-UCP2) that was generated previously 4 was used in the present study. Briefly, adenovirus vectors were generated using Cre-lox recombination of purified ⌿5 viral DNA and shuttle vector pAdEGI-UCP2. This vector coexpressed green fluorescent protein (GFP) and UCP2, driven by the inducible ecdysone promoter. The recombinant vectors were expanded and purified using cesium chloride gradients, yielding concentrations of 1ϫ10 10 plaqueforming units per milliliter. Functional expression was inferred from GFP visualization by fluorescence microscopy. The control vector (AdEGI) expressed only GFP, again driven by the ecdysone promoter. Transductions were carried out in culture medium (QBSF; Sigma) for 2 hours at 37°C on day 6 after the isolation of cardiomyocytes. Afterward, the myocytes were washed with virusfree medium and incubated with ponasterone A (Invitrogen) to induce expression from ecdysone-inducible promoter. The experiments were carried out at least 48 hours after transduction.
Immunoblot Analysis
Subcellular fractions of cells were prepared as described before. 17 Immunoblots were performed as described. 10 Primary antibodies for UCP2 and cytochrome c oxidase subunit IV were purchased from Alpha Diagnostic International and Molecular Probes, respectively.
Mitochondrial Oxygen Consumption Rate
For oxygen consumption measurements, cardiomyocytes were trypsinized for detachment from the dishes. After centrifugation, cells were resuspended in DMEM containing 25 mmol/L HEPES. Oxygen consumption was measured using an oxygen sensor (FOXY Fiber Optic Oxygen Sensors; Ocean Optics Inc) at 37°C in a stirred bath. The data for oxygen consumption rate were normalized by the protein concentration in each sample.
TUNEL Staining
TUNEL staining was performed according to the manufacturer's protocol (Roche) at 16 hours after application of 100 mol/L H 2 O 2 . Fluorescein labels incorporated in nucleotide polymers were detected by laser scanning confocal microscopy.
Caspase-3 Activity Assay
Caspase-3 activity was measured as described previously 18 by detection of the cleavage of a colorimetric caspase-3 substrate, N-acetyl-Asp-Glu-Val-Asp-p-nitroaniline, using an assay kit, ApoAlert CPP32 (Clontech), at 8 and 16 hours of 100 mol/L H 2 O 2 stimulation.
Loading of Cells With Fluorescent Indicators
For quantification of cellular viability, cells were double-stained with annexin V and propidium iodide (PI) according to manufacturer's instructions (Roche). To monitor ⌬⌿ m , cells were loaded with 100 nmol/L tetramethylrhodamine ethyl ester (TMRE) (Molecular Probes) at 37°C for 20 minutes. To monitor mitochondrial Ca 2ϩ level, cells were loaded with 2 mol/L rhod-2 AM (Molecular Probes) at 37°C for 30 minutes. We assayed ROS production, such as superoxide anion, hydrogen peroxide, and hydroxyl radical, using chloromethyl-2,7-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA, Molecular Probes). Cells were loaded with 2 mol/L CM-H 2 DCFDA at 37°C for 30 minutes, and the formation of the oxidized derivative, CM-DCF, was monitored.
Confocal Imaging
Cells plated on glass-bottom dishes were loaded with fluorescent probes as described above. After loading with each dye, cells were placed in phenol red-free DMEM supplemented with 25 mmol/L HEPES (pH 7.4). Cells were illuminated (488-and 568-nm lines of a krypton/argon laser), and images were taken by confocal microscopy (UltraVIEW; Perkin-Elmer). Time-lapse confocal imaging was carried out with various intervals between frames, using a ϫ40 objective lens for DCF and a ϫ20 objective lens for the other dyes.
Image Analysis
Quantitative image analysis was performed using image analysis software (ImageJ; http://rsb.info.nih.gov/ij/).
FACS Analysis
For FACS analysis of ⌬⌿ m , TMRE-loaded cells were harvested by trypsinization at the end of experimental protocols and analyzed using FACScan (20 000 cells/sample) (Becton Dickinson). The fluorescence intensity of TMRE was monitored at 582 nm (FL-2 channel). FACS data were analyzed using WinMDI software (http://facs.scripps.edu).
Statistical Analysis
Data are presented as meanϮSEM. Multiple comparisons among groups were carried out by one-way ANOVA with Fisher's leastsignificant difference as the post hoc test. A level of PϽ0.05 was accepted as statistically significant.
Results

Adenovirus-Mediated Delivery of UCP2 to Neonatal Cardiomyocytes
To deliver UCP2 to cultured cardiomyocytes, we used a recombinant adenovirus containing the full-length human UCP2 cDNA. Figure 1A shows the results of immunoblot analysis. UCP2 protein level was increased in AdEGI-UCP2 (AdUCP2, 20 multiplicity of infection [moi])-transduced cells compared with AdEGI-transduced cells in the mitochondrial fraction but not in the cytosolic fraction. UCP2 protein level was increased virus volume dependently up to 20 moi, but there was no difference between 20 and 40 moi (nϭ3). In Figure 1B , cells were stained with TMRE to examine the effect of UCP2 expression on ⌬⌿ m under basal conditions. AdUCP2-transduced cells showed partial depolarization of ⌬⌿ m (gray area) compared with AdEGI-transduced cells (thick line), verifying functional overexpression of UCP2. This degree of ⌬⌿ m dissipation is measurable but very modest compared with the catastrophic depolarization produced by the potent pharmacological uncoupler FCCP (thin line). We analyzed the intensity of fluorescence in the peak of the histogram in each group (nϭ5). Significant but moderate dissipation of ⌬⌿ m was observed in AdUCP2 cells compared with AdEGI. There was no difference between 20 and 40 moi. In Figure 1C , UCP2-transduced cells showed modest but statistically significant increases of oxygen consumption compared with AdEGI cells (nϭ7, PϽ0.05). A chemical uncoupler, FCCP (0.5 mol/L), increased oxygen consumption in both AdEGI and AdUCP2 cells to a similar (presumably maximal) level. However, the magnitude of the FCCPinduced increase was smaller in AdUCP2 compared with AdEGI. This is consistent with the idea that AdUCP2 cells have a higher uncoupled respiration under basal conditions. Conversely, sodium cyanide (5 mmol/L) suppressed the oxygen consumption rate in each group.
Effects of Overexpression of UCP2 on Cell Death
First, we examined the long-term effects of UCP2 overexpression on cell death. We performed TUNEL staining 16 hours after H 2 O 2 application. Representative images and quantitative data are shown in Figures 2A and 2B , respectively (nϭ4 for each group from two independent experiments). In the control group (AdEGI), 15 
Effects of Overexpression of UCP2 on Early Phase of Cell Death
To assess the effects of UCP2 overexpression in the early phase of cell injury, we investigated the alterations of annexin V and PI fluorescence in each group. Time-lapse confocal microscopy at 5-minute intervals began immediately after application of 100 mol/L H 2 O 2 . In AdEGIϩH 2 O 2 , annexin V fluorescence started to increase Ϸ20 minutes after H 2 O 2 application and gradually increased to a plateau at Ϸ100 minutes ( Figures 3A and 3B ). UCP2 remarkably suppressed this increase of annexin V fluorescence ( Figures 3A and 3B ). PI fluorescence was increased after 90 minutes of latency and reached the plateau at Ϸ150 minutes in AdEGIϩH 2 O 2 (Figures 3C and 3D ). This increase of PI fluorescence was also abrogated by UCP2 overexpression (Figures 3C and 3D (Figure 3D , inset). Because annexin V is an indicator of apoptosis and PI of necrosis, these results suggest that UCP2 overexpression reduces both types of cell death.
Effects of UCP2 Overexpression on ⌬⌿m
Dissipation of ⌬⌿ m is a critical event early in the process of cell death. 20 To examine whether preservation of ⌬⌿ m is associated with cardioprotective effects of UCP2, we assessed the change of TMRE fluorescence by H 2 O 2 stimulation in each group using FACS analysis. Incubation with 100 dependently (nϭ3 for each group) ( Figure 4B ). Treatment with 1 mol/L ponasterone A without AdUCP2 transfection had no effect (data not shown). Inhibition of mitoK ATP channels by 5-hydroxydecanoate (5HD, 500 mol/L) or glibenclamide (10 mol/L) did not cancel ⌬⌿ m preservation by UCP2 overexpression (nϭ3 for each group) ( Figure 4C ). Thus, whereas the effects of UCP2 mimic those of mitoK ATP channel openers, 21 they are not dependent on mitoK ATP channel activation.
Time-Lapse Analysis of ⌬⌿m Loss
To examine time-dependent changes of ⌬⌿ m on a single-cell basis, confocal microscopy was performed using cells loaded with TMRE. Time-lapse scanning began immediately after application of 100 mol/L H 2 O 2 . At first, we confirmed that TMRE fluorescence did not change during 70 minutes of scanning in AdEGI ( Figure 5A ). In contrast, cells treated with H 2 O 2 progressively lost red fluorescence intensity, indicating irreversible dissipation of ⌬⌿ m ( Figure 5B ). TMRE fluorescence was remarkably preserved in AdUCP2ϩH 2 O 2 ( Figure  5C ). Twenty cells were randomly selected in each group, and TMRE fluorescence intensity from each cell was plotted in Figure 5D . TMRE fluorescence intensity of individual cells rapidly decreased in AdEGIϩH 2 O 2 , but UCP2 overexpression prevented the loss of ⌬⌿ m induced by H 2 O 2 in most cells. The bottom panel in Figure 5D shows the average of TMRE fluorescence intensity from 20 randomly selected cells in each group.
Effects of UCP2 Overexpression on Mitochondrial Ca 2؉ Overload
Dissipation of ⌬⌿ m is caused by the opening of PTP. Ca 2ϩ overload in mitochondria is one of the critical triggers of cell death and is known to open the PTP. We examined the effects of UCP2 overexpression on mitochondrial Ca 2ϩ level using the mitochondrial Ca 2ϩ -sensitive dye rhod-2. Time-lapse confocal microscopy began after the addition of 100 mol/L H 2 O 2 . We first confirmed that rhod-2 fluorescence did not change during 70 minutes of scanning in AdEGI ( Figure 6A ). Rhod-2 fluorescence was rapidly and dramatically augmented in AdEGIϩH 2 O 2 at Ϸ30 minutes after H 2 O 2 application ( Figure 6B ). UCP2 overexpression almost completely inhibited the Ca 2ϩ surge observed in AdEGIϩH 2 O 2 ( Figure 6C ). Figure 6D shows the average of rhod-2 fluorescence intensity from 20 randomly selected cells in each group.
Effects of UCP2 Overexpression on ROS Production
ROS is another trigger of PTP opening. We investigated the effects of UCP2 overexpression on ROS production using time-lapse confocal microscopy. No changes in fluorescence were observed in AdEGI ( Figure 7B, Ⅵ) . In AdEGIϩH 2 O 2 , DCF fluorescence increased immediately after H 2 O 2 application and gradually reached a plateau at Ϸ40 minutes ( Figures 7A and  7B, ⅷ) . UCP2 overexpression abrogated the increase in DCF fluorescence ( Figures 7A and 7B, ⅙) . Furthermore, the effects of UCP2 overexpression on ROS production were confirmed using an entirely different form of oxidant stress, namely doxorubicin, which exerts cardiotoxicity by increasing ROS production in mitochondria. 22, 23 Incubation with 50 mol/L doxorubicin for 3 hours markedly increased DCF fluorescence compared with AdEGI (PϽ0.001) ( Figure 7C ), but UCP2 overexpression significantly prevented the increase of fluorescence (PϽ0.001 versus AdEGIϩdoxorubicin) (nϭ6 for each group from two independent experiments) ( Figure 7C ).
Discussion
The major findings in the present study are as follows. First, UCP2 overexpression suppressed markers of cell death such as increased TUNEL positivity, caspase-3 activity, phosphatidylserine exposure, and PI positivity induced by oxidative stress. Second, mitochondrial Ca 2ϩ overload and increased ROS production in mitochondria, and subsequent ⌬⌿ m loss induced by oxidative stress, were prevented by UCP2 overexpression in a dose-dependent manner. These results demonstrate that overexpression of UCP2 protects cardiomyocytes against oxidative stress by preserving the integrity of early processes that would normally be recruited as part of the mitochondrial death pathway.
Cardiomyocytes contain abundant mitochondria to maintain cardiac function, which requires a large amount of energy. The plethora of mitochondria can potentially produce ROS that contribute to ischemia/reperfusion injury in the heart. 24 The mitochondrial respiratory chain generates ROS, especially in state IV respiration, when the electrochemical gradient between the mitochondrial inner membrane is high and the rate of electron transport is limited. In this context, UCP2 should affect ROS production by dissipating the electrochemical gradient. Indeed, the association of UCP2 and ROS production has been described in several reports. GDP, an inhibitor of UCP2, raised mitochondrial membrane potential and increased H 2 O 2 production in mitochondrial fractions of liver, spleen, and thymus. 25 Macrophages from mice lacking UCP2 generate more ROS than wild-type mice and had a remarkably increased resistance to Toxoplasma gondii infection. 7 Transfection of UCP2 cDNA in murine macrophage cell line reduced lipopolysaccharide-induced intracellular ROS production, 16 and the lack of UCP2 in blood cells accelerates atherosclerotic plaque development, probably by increasing ROS production. 26 This evidence strongly supports the possibility that the principal role of UCP2 is regulation of ROS production in mitochondria, although the precise mechanism of this effect has not been established. Furthermore, a recent report demonstrated that superoxide activated UCPs in various tissues, indicating that UCPs may be recruited endogenously as a compensatory mechanism to counteract oxidative stress. 27 Consistent with these observations, UCP2 overexpression reduced ROS production in the present study. Exogenous H 2 O 2 -induced ROS production may not originate only from mitochondrial respiration but also from other reactions, such as the Fenton reaction or interactions with mitochondrial respiratory com- ponents. Therefore, we cannot be certain that reduced ROS production was caused by increased respiration rate in mitochondria. The present result that UCP2 overexpression suppressed the increase in ROS production by doxorubicin, which is known to increase ROS production in mitochondria, 22, 28, 29 indirectly supports our hypothesis. As another possibility, interaction of UCP2 with coenzyme Q, may prevent coenzyme Q from H 2 O 2 -oxidizing action and thereby reduce ROS production. 30 This is the first study that shows UCP2 overexpression inhibited mitochondrial Ca 2ϩ overload, an important trigger of the mitochondrial death pathway. One possible mechanism is that this effect may simply be attributable to the partial depolarization of ⌬⌿ m , which decreases the driving force for Ca 2ϩ uptake into the mitochondrial matrix. Otherwise, inhibition of Ca 2ϩ overload may be a secondary effect of reduced ROS production. In fact, ROS was reported to trigger Ca 2ϩ increase during hypoxia in pulmonary arterial myocytes. 31 On the contrary, ROS levels under oxidative stress may depend on extracellular Ca 2ϩ concentration. 32 Therefore, ROS and Ca 2ϩ overload may be tightly coupled and there could be a mutual requirement for each to reach its maximal levels. 33 PTP is a major player in the cell death pathway. Opening of PTP results in the loss of ⌬⌿ m , massive swelling of mitochondria, rupture of the outer membrane, and release of intermembrane components that induce cell death. 34 Hence, inhibition of ⌬⌿ m loss by UCP2 overexpression may be mediated by prevention of Ca 2ϩ overload or ROS production in mitochondria, such that PTP never opens.
Activation of mitoK ATP channels has cardioprotective effects, and inhibition of mitochondrial Ca 2ϩ overload and subsequent preservation of ⌬⌿ m are considered the mechanisms of these effects. 10 -12 We examined the possibility that the cardioprotective effects by UCP2 overexpression observed in the present study may be mediated by activation of mitoK ATP channels. Neither 5HD nor glibenclamide altered the effects of UCP2 overexpression, indicating that the cardioprotection of UCP2 is not dependent on mitoK ATP channels. Nevertheless, the fact that UCP2 overexpression mimics the effects of mitoK ATP channel openers supports the idea that mitoK ATP channels may be cardioprotective because they are mild uncouplers. 11 Although the present findings convincingly demonstrate protective effects of UCP2 overexpression, other models provide discordant results. Namely, a recent report demonstrated that overexpression of UCP2 in HeLa cells prompted cellular oncosis by dramatically decreasing the mitochondrial membrane potential. 37 Although we cannot define the reason for the discrepancy, UCP2 overexpression may result in different downstream effects in various cell types. In fact, UCP2 overexpression did not alter the growth and viability of fibroblasts, while causing fatal response in HeLa cells. 37 Furthermore, UCP2 negatively regulates insulin secretion in pancreatic ␤ cells. 4 -6 In macrophages, UCP2 contributes to immune function by regulating ROS production. 7 A recent study, published while the present article was in revision, demonstrated that transfection of UCP1 conferred cellprotective effects against hypoxia/reoxygenation in H9c2 cells. 38 Another study showed that UCP2 expression levels were inversely correlated with caspase-3 activation in neurons. 39 Taking these results together, the physiological role of UCP2 may actually be similar in the brain and heart.
Since the discovery of UCP2, several reports have described the regulation of UCP2 mRNA expression in the heart. Thyroid hormone, ␤-adrenergic stimulation, 40 and fatty acids 41 are known as regulators of UCP2 expression. However, the regulation and the functional role of UCP2 in the pathological heart are largely unexplored. In a recent study, UCP2 expression was increased in the hearts of rats with cardiomyopathy induced by aortic regurgitation. 42 In contrast, UCP2 expression was decreased in human hearts with idiopathic cardiomyopathy, ischemic cardiomyopathy, and peripartum cardiomyopathy. 43 These studies shed some light on UCP2 expression in the pathological heart, but the functional role is still obscure. Although the results of the present study are restricted to cultured neonatal cardiomyocytes, they suggest that UCP2 may mitigate ischemia-reperfusion injury by reducing cell death. Future studies are necessary to identify the effects of UCP2 overexpression or upregulation on cardiac function in adult heart.
